NVAX - What's Going On With Moderna Stock Wednesday? | Benzinga
Moderna, Inc (NASDAQ: MRNA) shares are trading higher Wednesday. The company announced positive data from its combination vaccine against influenza and Covid-19.
What To Know: Moderna highlighted positive interim results from its Phase 1/2 trial of mRNA-1083, the company's investigational vaccine for the flu and Covid.
The combination vaccine was compared to the Spikevax booster in the trials. Moderna said it achieved hemagglutination inhibition antibody titers similar to or greater than both licensed quadrivalent flu vaccines. It also achieved SARS-CoV-2 ...